应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TVGNW Tevogen Bio Holdings Inc.
交易中 03-21 13:22:59 EDT
0.0549
-0.0019
-3.35%
最高
0.0567
最低
0.0430
成交量
10.19万
今开
0.0480
昨收
0.0568
日振幅
24.12%
总市值
0.00
流通市值
0.00
总股本
0.00
成交额
5,025
换手率
--
流通股本
0.00
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Tevogen Bio Holdings Inc.盘中异动 早盘快速下跌5.18%报1.08美元
市场透视 · 03-10
Tevogen Bio Holdings Inc.盘中异动 早盘快速下跌5.18%报1.08美元
Tevogen Bio Holdings Inc.盘中异动 快速跳水5.35%
市场透视 · 03-05
Tevogen Bio Holdings Inc.盘中异动 快速跳水5.35%
Tevogen Bio Holdings Inc.盘中异动 早盘大幅拉升5.93%报1.25美元
市场透视 · 03-04
Tevogen Bio Holdings Inc.盘中异动 早盘大幅拉升5.93%报1.25美元
Tevogen Bio Holdings Inc.盘中异动 股价大跌5.08%报1.22美元
市场透视 · 03-03
Tevogen Bio Holdings Inc.盘中异动 股价大跌5.08%报1.22美元
Tevogen Bio Holdings Inc.盘中异动 临近午盘股价大涨6.43%
市场透视 · 02-27
Tevogen Bio Holdings Inc.盘中异动 临近午盘股价大涨6.43%
Tevogen Bio Holdings Inc.盘中异动 急速跳水5.44%
市场透视 · 02-25
Tevogen Bio Holdings Inc.盘中异动 急速跳水5.44%
Tevogen Bio Holdings Inc.盘中异动 早盘大幅下跌5.89%报1.33美元
市场透视 · 02-24
Tevogen Bio Holdings Inc.盘中异动 早盘大幅下跌5.89%报1.33美元
Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.48%
市场透视 · 02-21
Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.48%
Tevogen Bio Holdings Inc.盘中异动 股价大涨5.38%
市场透视 · 02-18
Tevogen Bio Holdings Inc.盘中异动 股价大涨5.38%
Tevogen Bio Holdings Inc.盘中异动 股价大跌5.13%
市场透视 · 02-14
Tevogen Bio Holdings Inc.盘中异动 股价大跌5.13%
Tevogen Bio Holdings Inc.盘中异动 大幅下挫5.42%报1.57美元
市场透视 · 02-13
Tevogen Bio Holdings Inc.盘中异动 大幅下挫5.42%报1.57美元
Tevogen Bio Holdings Inc.盘中异动 早盘股价大涨5.48%报1.54美元
市场透视 · 02-04
Tevogen Bio Holdings Inc.盘中异动 早盘股价大涨5.48%报1.54美元
Tevogen Bio Holdings Inc.盘中异动 股价大跌6.04%
市场透视 · 02-03
Tevogen Bio Holdings Inc.盘中异动 股价大跌6.04%
Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.17%报1.38美元
市场透视 · 01-30
Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.17%报1.38美元
Tevogen Bio Holdings Inc.盘中异动 早盘急速上涨5.23%
市场透视 · 01-29
Tevogen Bio Holdings Inc.盘中异动 早盘急速上涨5.23%
Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌12.20%报1.48美元
市场透视 · 01-28
Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌12.20%报1.48美元
Tevogen Bio Holdings Inc.盘中异动 大幅拉升10.87%报1.53美元
市场透视 · 01-24
Tevogen Bio Holdings Inc.盘中异动 大幅拉升10.87%报1.53美元
Tevogen Bio Holdings Inc.盘中异动 股价大涨5.19%报1.42美元
市场透视 · 01-23
Tevogen Bio Holdings Inc.盘中异动 股价大涨5.19%报1.42美元
Tevogen Bio Holdings Inc.盘中异动 下午盘快速上涨5.24%报1.31美元
市场透视 · 01-15
Tevogen Bio Holdings Inc.盘中异动 下午盘快速上涨5.24%报1.31美元
Tevogen Bio Holdings Inc.盘中异动 急速跳水5.04%报1.31美元
市场透视 · 01-14
Tevogen Bio Holdings Inc.盘中异动 急速跳水5.04%报1.31美元
加载更多
公司概况
公司名称:
Tevogen Bio Holdings Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Tevogen Bio Holdings Inc.于2021年4月21日在开曼群岛注册成立,后合并重组为特拉华州公司。Tevogen Bio是一家临床阶段的专业免疫疗法公司,利用自然界最强大的免疫武器之一—CD8 +细胞毒性T淋巴细胞,开发现成的、未经基因改造的精准T细胞疗法,用于治疗传染病、癌症和神经系统疾病,旨在解决大量患者群体的重大未满足需求。
发行价格:
--
{"stockData":{"symbol":"TVGNW","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings Inc.","latestPrice":0.0549,"timestamp":1742573759953,"preClose":0.0568,"halted":0,"volume":101946,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-0.0019,"latestTime":"03-21 13:22:59 EDT","open":0.048,"high":0.0567,"low":0.043,"amount":5024.648794776,"amplitude":0.241197,"askPrice":0.0568,"askSize":10500,"bidPrice":0.041,"bidSize":49905,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1742587200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0568,"preHourTrading":{"tag":"盘前","latestPrice":0.0575,"preClose":0.0568,"latestTime":"08:11 EDT","volume":1000,"amount":57.5,"timestamp":1742559099912},"volumeRatio":0.472303},"requestUrl":"/m/hq/s/TVGNW","defaultTab":"news","newsList":[{"id":"2518527981","title":"Tevogen Bio Holdings Inc.盘中异动 早盘快速下跌5.18%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518527981","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518527981?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:01","pubTimestamp":1741618870,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时01分,Tevogen Bio Holdings Inc.股票出现波动,股价快速跳水5.18%。截至发稿,该股报1.08美元/股,成交量11.0718万股,换手率0.06%,振幅5.27%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.44%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023011198a2b2d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023011198a2b2d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2517940697","title":"Tevogen Bio Holdings Inc.盘中异动 快速跳水5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517940697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517940697?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:48","pubTimestamp":1741196930,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时48分,Tevogen Bio Holdings Inc.股票出现波动,股价大幅下挫5.35%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为1.20%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306014850abe9e98d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306014850abe9e98d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2516677087","title":"Tevogen Bio Holdings Inc.盘中异动 早盘大幅拉升5.93%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516677087?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:47","pubTimestamp":1741099627,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时47分,Tevogen Bio Holdings Inc.股票出现异动,股价大幅上涨5.93%。截至发稿,该股报1.25美元/股,成交量15.5608万股,换手率0.09%,振幅3.39%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.45%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503042247089639497e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503042247089639497e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2516655652","title":"Tevogen Bio Holdings Inc.盘中异动 股价大跌5.08%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516655652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516655652?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:06","pubTimestamp":1741025204,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时06分,Tevogen Bio Holdings Inc.股票出现异动,股价快速下挫5.08%。截至发稿,该股报1.22美元/股,成交量58.3924万股,换手率0.33%,振幅8.20%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304020644989a40df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304020644989a40df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2514387794","title":"Tevogen Bio Holdings Inc.盘中异动 临近午盘股价大涨6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514387794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514387794?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:41","pubTimestamp":1740674462,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时41分,Tevogen Bio Holdings Inc.股票出现异动,股价急速拉升6.43%。截至发稿,该股报1.32美元/股,成交量15.4541万股,换手率0.09%,振幅4.44%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.60%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022800410398952a4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022800410398952a4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2514011891","title":"Tevogen Bio Holdings Inc.盘中异动 急速跳水5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514011891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514011891?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:18","pubTimestamp":1740500335,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时18分,Tevogen Bio Holdings Inc.股票出现波动,股价大幅跳水5.44%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.59%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001855abdc97ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001855abdc97ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2513187720","title":"Tevogen Bio Holdings Inc.盘中异动 早盘大幅下跌5.89%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513187720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513187720?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:02","pubTimestamp":1740409333,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时02分,Tevogen Bio Holdings Inc.股票出现异动,股价急速跳水5.89%。截至发稿,该股报1.33美元/股,成交量16.2036万股,换手率0.09%,振幅4.95%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.24%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230213962ea093&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230213962ea093&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2513294469","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513294469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513294469?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:33","pubTimestamp":1740151998,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时33分,Tevogen Bio Holdings Inc.股票出现异动,股价急速跳水5.48%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.09%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221233318abd7bd64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221233318abd7bd64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2512162675","title":"Tevogen Bio Holdings Inc.盘中异动 股价大涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512162675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512162675?lang=zh_cn&edition=full","pubTime":"2025-02-19 00:08","pubTimestamp":1739894881,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日00时08分,Tevogen Bio Holdings Inc.股票出现异动,股价快速拉升5.38%。截至发稿,该股报1.67美元/股,成交量39.7288万股,换手率0.23%,振幅4.99%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.83%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190008019627a899&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190008019627a899&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2511618168","title":"Tevogen Bio Holdings Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511618168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511618168?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:14","pubTimestamp":1739553295,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日01时14分,Tevogen Bio Holdings Inc.股票出现波动,股价大幅下挫5.13%。截至发稿,该股报1.48美元/股,成交量45.9814万股,换手率0.26%,振幅6.10%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.54%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215011455962340b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215011455962340b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2511578128","title":"Tevogen Bio Holdings Inc.盘中异动 大幅下挫5.42%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511578128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511578128?lang=zh_cn&edition=full","pubTime":"2025-02-14 01:14","pubTimestamp":1739466887,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日01时14分,Tevogen Bio Holdings Inc.股票出现波动,股价急速下跌5.42%。截至发稿,该股报1.57美元/股,成交量64.4783万股,换手率0.37%,振幅6.63%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.84%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021401144798844bf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021401144798844bf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2509668294","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大涨5.48%报1.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509668294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509668294?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:48","pubTimestamp":1738684089,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时48分,Tevogen Bio Holdings Inc.股票出现波动,股价急速拉升5.48%。截至发稿,该股报1.54美元/股,成交量32.1421万股,换手率0.18%,振幅8.22%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.80%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204234810a23937f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204234810a23937f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2508354141","title":"Tevogen Bio Holdings Inc.盘中异动 股价大跌6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508354141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508354141?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:30","pubTimestamp":1738593043,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时30分,Tevogen Bio Holdings Inc.股票出现异动,股价急速跳水6.04%。截至发稿,该股报1.40美元/股,成交量18.7496万股,换手率0.11%,振幅1.34%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322304398796e7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322304398796e7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2507214166","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.17%报1.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507214166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507214166?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:35","pubTimestamp":1738247703,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时35分,Tevogen Bio Holdings Inc.股票出现波动,股价大幅下跌5.17%。截至发稿,该股报1.38美元/股,成交量12.6199万股,换手率0.07%,振幅2.07%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.01%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223503abbd4d07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223503abbd4d07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2507663123","title":"Tevogen Bio Holdings Inc.盘中异动 早盘急速上涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507663123","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507663123?lang=zh_cn&edition=full","pubTime":"2025-01-29 22:41","pubTimestamp":1738161674,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日22时41分,Tevogen Bio Holdings Inc.股票出现异动,股价急速拉升5.23%。截至发稿,该股报1.61美元/股,成交量57.0204万股,换手率0.33%,振幅8.44%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.10%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129224114a2336905&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129224114a2336905&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2506987514","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌12.20%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506987514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506987514?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:31","pubTimestamp":1738074691,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时31分,Tevogen Bio Holdings Inc.股票出现异动,股价快速下挫12.20%。截至发稿,该股报1.48美元/股,成交量97.4991万股,换手率0.56%,振幅-87.50%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.01%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223131a2326ea3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223131a2326ea3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":1},{"id":"2505251865","title":"Tevogen Bio Holdings Inc.盘中异动 大幅拉升10.87%报1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505251865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505251865?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:31","pubTimestamp":1737729082,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时31分,Tevogen Bio Holdings Inc.股票出现波动,股价快速拉升10.87%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.30%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223122abb74e30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223122abb74e30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2505204745","title":"Tevogen Bio Holdings Inc.盘中异动 股价大涨5.19%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505204745","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505204745?lang=zh_cn&edition=full","pubTime":"2025-01-24 03:01","pubTimestamp":1737658877,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日03时01分,Tevogen Bio Holdings Inc.股票出现异动,股价急速拉升5.19%。截至发稿,该股报1.42美元/股,成交量65.8067万股,换手率0.38%,振幅7.04%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为1.13%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124030118960e75e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124030118960e75e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2503608420","title":"Tevogen Bio Holdings Inc.盘中异动 下午盘快速上涨5.24%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503608420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503608420?lang=zh_cn&edition=full","pubTime":"2025-01-16 04:02","pubTimestamp":1736971345,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日04时02分,Tevogen Bio Holdings Inc.股票出现波动,股价快速拉升5.24%。截至发稿,该股报1.31美元/股,成交量59.8825万股,换手率0.34%,振幅10.08%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为1.39%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501160402259604fae5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501160402259604fae5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2503797245","title":"Tevogen Bio Holdings Inc.盘中异动 急速跳水5.04%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503797245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503797245?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:37","pubTimestamp":1736865454,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时37分,Tevogen Bio Holdings Inc.股票出现异动,股价大幅下挫5.04%。截至发稿,该股报1.31美元/股,成交量9.8506万股,换手率0.06%,振幅1.42%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.19%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223734a221ba09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223734a221ba09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://semperparatusspac.com","stockEarnings":[{"period":"1week","weight":-0.1111},{"period":"1month","weight":-0.2837},{"period":"3month","weight":0.0365},{"period":"6month","weight":4.0265},{"period":"1year","weight":-0.1647},{"period":"ytd","weight":0.0519}],"compareEarnings":[{"period":"1week","weight":0.0255},{"period":"1month","weight":-0.0752},{"period":"3month","weight":-0.0434},{"period":"6month","weight":-0.0049},{"period":"1year","weight":0.0865},{"period":"ytd","weight":-0.0351}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tevogen Bio Holdings Inc.于2021年4月21日在开曼群岛注册成立,后合并重组为特拉华州公司。Tevogen Bio是一家临床阶段的专业免疫疗法公司,利用自然界最强大的免疫武器之一—CD8 +细胞毒性T淋巴细胞,开发现成的、未经基因改造的精准T细胞疗法,用于治疗传染病、癌症和神经系统疾病,旨在解决大量患者群体的重大未满足需求。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":1.578518},{"month":2,"riseRate":0.25,"avgChangeRate":0.208292},{"month":3,"riseRate":0.5,"avgChangeRate":0.010246},{"month":4,"riseRate":0,"avgChangeRate":-0.282545},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.106184},{"month":6,"riseRate":0,"avgChangeRate":-0.176798},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.059726},{"month":8,"riseRate":0.333333,"avgChangeRate":0.1125},{"month":9,"riseRate":0,"avgChangeRate":-0.256349},{"month":10,"riseRate":0.333333,"avgChangeRate":1.818294},{"month":11,"riseRate":0,"avgChangeRate":-0.508558},{"month":12,"riseRate":0.333333,"avgChangeRate":0.083737}],"exchange":"NASDAQ","name":"Tevogen Bio Holdings Inc.","nameEN":"Tevogen Bio Holdings Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tevogen Bio Holdings Inc.(TVGNW)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tevogen Bio Holdings Inc.(TVGNW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tevogen Bio Holdings Inc.,TVGNW,Tevogen Bio Holdings Inc.股票,Tevogen Bio Holdings Inc.股票老虎,Tevogen Bio Holdings Inc.股票老虎国际,Tevogen Bio Holdings Inc.行情,Tevogen Bio Holdings Inc.股票行情,Tevogen Bio Holdings Inc.股价,Tevogen Bio Holdings Inc.股市,Tevogen Bio Holdings Inc.股票价格,Tevogen Bio Holdings Inc.股票交易,Tevogen Bio Holdings Inc.股票购买,Tevogen Bio Holdings Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tevogen Bio Holdings Inc.(TVGNW)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tevogen Bio Holdings Inc.(TVGNW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}